ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Nicoletta Colombo; Cristiana Sessa; Andreas du Bois; Jonathan A. Ledermann; W. Glenn McCluggage; Iain A. McNeish; Philippe Morice; Sandro Pignata; Isabelle Ray‐Coquard; Ignace Vergote; Thaïs Baert; I. Belaroussi; A. Dashora; Siel Olbrecht; François Planchamp; Denis Querleu; Thaïs Baert; Susana Banerjee; I. Belaroussi; Paweł Blecharz; Ilan Bruchim; David Cibula; Nicoletta Colombo; Nicole Concin; Ben Davidson; A. Dashora; Mojgan Devouassoux‐Shisheboran; Andreas du Bois; Annamaria Ferrero; Rosalind Glasspool; Antonio González-Martı́n; Viola Heinzelmann‐Schwarz; Florence Joly; J.W. Kim; Frédéric Kridelka; Jonathan A. Ledermann; Domenica Lorusso; Sven� Mahner; W. Glenn McCluggage; Iain A. McNeish; Mikio Mikami; Mansoor Raza Mirza; Philippe Morice; Shibani Nicum; Siel Olbrecht; Dearbhaile M. O’Donnell; Patricia Pautier; François Planchamp; Sandro Pignata; Denis Querleu; Isabelle Ray‐Coquard; Alexandros Rodolakis; Jalid Sehouli; Fatih Selçukbırıcık; Cristiana Sessa; Nilanchali Singh; David S.P. Tan; D. Timmerman; Germana Tognon; Jacobus van der Velden; Ignace Vergote; Petronella O. Witteveen; Alain G. Zeimet

doi:10.1093/annonc/mdz062

Keywords

MedicineDiseaseOvarian cancerOncologyPathologyCancerMolecular pathologyConsensus conferenceInternal medicineGene

Affiliated Institutions

Related Publications

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

Nicole Concin , Xavier Matías‐Guiu , Ignace Vergote +25 more

A European consensus conference on endometrial carcinoma was held in 2014 to produce multi-disciplinary evidence-based guidelines on selected questions. Given the large body of ...

2020 International Journal of Gynecologica... 1755 citations

Cervical cancer

Paul A. Cohen , A. Jhingran , Ana Oaknin +1 more

Each year, more than half a million women are diagnosed with cervical cancer and the disease results in over 300 000 deaths worldwide. High-risk subtypes of the human papilloma ...

2019 The Lancet 2286 citations

Epithelial ovarian cancer

Stéphanie Lheureux , Charlie Gourley , Ignace Vergote +1 more

Epithelial ovarian cancer generally presents at an advanced stage and is the most common cause of gynaecological cancer death. Treatment requires expert multidisciplinary care. ...

2019 The Lancet 1776 citations

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Stéphanie Lheureux , Marsela Braunstein , Amit M. Oza

Abstract Ovarian cancer is the second most common cause of gynecologic cancer death in women around the world. The outcomes are complicated, because the disease is often diagnos...

2019 CA A Cancer Journal for Clinicians 1417 citations

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

Kathleen N. Moore , Nicoletta Colombo , Giovanni Scambia +18 more

The use of maintenance therapy with olaparib provided a substantial benefit with regard to progression-free survival among women with newly diagnosed advanced ovarian cancer and...

2018 New England Journal of Medicine 2632 citations

Publication Info

Year: 2019
Type: article
Volume: 30
Issue: 5
Pages: 672-705
Citations: 1060
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1060

OpenAlex

Cite This

APA Style

                            
                                
                                    Nicoletta Colombo, 
                                
                                    Cristiana Sessa, 
                                
                                    Andreas du Bois
                                
                                et al.
                            
                            (2019). 
                            ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. 
                            Annals of Oncology
                            , 30
                            (5)
                            , 672-705.
                            https://doi.org/10.1093/annonc/mdz062
                        

Identifiers

DOI: 10.1093/annonc/mdz062